CancerLife, a Digital Health Company, With the Validation Institute, Announces Results of Its Phase 3 Trial That Raised EQ-5 Quality of Life (QOL) Scores by 14.3%
June 02, 2022 09:30 ET
|
CancerLife
PHILADELPHIA, June 02, 2022 (GLOBE NEWSWIRE) -- CancerLife, a digital therapeutics company with the Validation Institute, announced the results of its two-arm, fully randomized Phase 3 clinical...
Enlivex Announces New Preclinical Data in Ovarian Cancer Showing a Substantial Survival Benefit when Allocetra is Combined with PD-1 Checkpoint Inhibition at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 31, 2022 08:00 ET
|
Enlivex Therapeutics Ltd
Stand-alone therapy with PD1 checkpoint inhibitors has shown limited efficacy against ovarian cancer, with response rates in prior clincical trials ranging from 7-15%. This contributes to poor patient...
Ovarian Cancer Market to reach a market size of USD 19.92 Billion by 2030 growing at a CAGR of 23.8%: Straits Research
May 30, 2022 12:50 ET
|
Straits Research
New York, United States, May 30, 2022 (GLOBE NEWSWIRE) -- Ovarian cancer drugs are sold to treat ovarian cancer in the Ovarian Cancer Market. The leading cause of ovarian cancer is abnormal cell...
Celsion Corporation Announces Stock Consolidation
February 28, 2022 08:30 ET
|
Celsion Corporation
LAWRENCEVILLE, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced...
Global Community Oncology Services Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
January 10, 2022 04:23 ET
|
Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Community Oncology Services Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
VBL Therapeutics to Report Third Quarter Financial Results on November 15
November 08, 2021 08:00 ET
|
VBL Therapeutics
TEL AVIV, Israel and NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical stage company developing first-in-class therapeutics for difficult-to-treat malignant...
Global $892 Mn Clinical Oncology Next Generation Sequencing Markets to 2028 by Technology (WGS, WES) & Application (Screening, Companion Diagnostics)
October 04, 2021 10:53 ET
|
Research and Markets
Dublin, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Oncology Next Generation Sequencing Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global clinical...
Immunicum och University Medical Center Groningen erhåller bidrag från Health ~ Holland för fortsatt utveckling av vaccin mot canceråterfall vid äggstockscancer
September 08, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 8 september 2021 Immunicum och University Medical Center Groningen erhåller bidrag från Health ~ Holland för fortsatt utveckling av vaccin mot canceråterfall vid...
Immunicum and the University Medical Center Groningen Receive a Grant from Health~Holland to Broaden Cancer Relapse Vaccine Development for Ovarian Cancer
September 08, 2021 02:00 ET
|
Immunicum AB
Press Release 8 September 2021 Immunicum and the University Medical Center Groningen Receive a Grant from Health~Holland to Broaden Cancer Relapse Vaccine Development for Ovarian Cancer ...
THE NATIONAL OVARIAN CANCER COALITION (NOCC) TO HOST ITS ANNUAL TOGETHER IN TEAL® - EVERYWHERE AS ONE NATIONAL BROADCAST CELEBRATION DURING SEPTEMBER AWARENESS MONTH ON SATURDAY, SEPTEMBER 25, 2021
September 01, 2021 05:10 ET
|
National Ovarian Cancer Coalition
Dallas, TX, Sept. 01, 2021 (GLOBE NEWSWIRE) -- During Ovarian Cancer Awareness Month, The National Ovarian Cancer Coalition (NOCC) will host its National Broadcast Celebration on Saturday, September...